The most recent study from Future Market Insights (FMI) projects the Global Air Fluidized Therapy Beds Industry to develop at an impressive compound annual growth rate (CAGR) of 5.7% between 2023 and 2033. By 2033, the market is predicted to have increased from its present valuation of about US$ 700 million to an astounding US$ 1,135 million.
Air fluidized therapy beds, also known as low-air-loss mattresses or alternating pressure mattresses, are designed to provide optimal support and pressure relief to patients, especially those who are immobile or bedridden for extended periods. The growing demand for these beds can be attributed to several factors, including the increasing prevalence of chronic conditions such as obesity, diabetes, and cardiovascular diseases, which require prolonged bed rest. Additionally, the rising geriatric population and the growing awareness about the benefits of air-fluidized therapy beds are also expected to drive the market’s growth.
The demand for these beds is on the rise worldwide, driven by technological innovations and advancements in medical treatments. Hospitals are increasingly adopting air-fluidized therapy beds to cater to the evolving needs of patients and provide cutting-edge healthcare solutions. The beds are not only crucial for burn patients but are also gaining prominence in addressing skin-related conditions.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5035
Global Air Fluidized Therapy Beds Industry Key Takeaways
- By 2033, the air fluidized therapy bed market in the United Kingdom is likely to expand, with a CAGR of 4.7%.
- In 2022, the United States developed the air fluidized therapy bed business with a share of 36%.
- The air fluidized therapy bed market grew considerably to US$ 635.3 million in 2022.
- The air-fluidized therapy bed sector expanded at a CAGR of 4.1% from 2018 to 2022.
- By 2033, China’s air-fluidized therapy bed market is projected to develop with a CAGR of 7%.
- By 2033, India’s air-fluidized therapy bed industry is projected to expand with a CAGR of 5.7%.
- Japan’s air fluidized therapy bed industry grew significantly, with a 3.8% share in 2022.
- Australia’s air-fluidized therapy bed is likely to expand with a CAGR of 5.1% by 2033.
- Germany’s air fluidized therapy bed business grew, with a share of 8.2% in 2022.
- In 2022, based on the indication, pressure ulcers dominated the market, with a share of 57.3%.
- In 2022, the hospitals segment dominated the market, with a share of 62.1%, based on end-user
Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5035
Global Air Fluidized Therapy Beds Industry Competitors Winning Strategies
Local and regional manufacturers serve certain geographic areas through regionalized customer assistance, affordable solutions, and in-depth knowledge of regional healthcare practices and laws.
Gaining the faith and confidence of healthcare institutions, experts, and end users is imperative for market players, and compliance with regulatory requirements and certifications is key to this.
To guarantee the best possible use of air-fluidized treatment beds, businesses offer outstanding customer service, prompt maintenance assistance, and thorough training programs for healthcare professionals.
Baxter became the top Medtech company in the world in December 2021 when it acquired Hill-Rom for US$ 15 billion. As a result, Baxter improved its technology, giving patients greater treatment in hospitals and at home. Moreover, Baxter anticipates a significant ROIC from this purchase.
Global Air Fluidized Therapy Beds Industry Key players
- Hill-Rom,
- Dolphin System
- AURORA MFG,
- American Medical Equipment
- Blue Chip Medical
- Akthel Healthcare BV
- ArjoHuntleigh
Click Here To Buy Your Full Report
https://www.futuremarketinsights.com/checkout/5035
Global Air Fluidized Therapy Beds Industry Key Segments
By Indication:
- Pressure Ulcers
- Burns
- Other Indications
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Other End Users
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
